These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 10858175
1. The cost-effectiveness of sildenafil. Smith KJ, Roberts MS. Ann Intern Med; 2000 Jun 20; 132(12):933-7. PubMed ID: 10858175 [Abstract] [Full Text] [Related]
2. Tough choices: the cost-effectiveness of sildenafil. McGarvey MR. Ann Intern Med; 2000 Jun 20; 132(12):994-5. PubMed ID: 10858184 [No Abstract] [Full Text] [Related]
8. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate. Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S. J Sex Med; 2006 Jul 20; 3(4):668-675. PubMed ID: 16839323 [Abstract] [Full Text] [Related]
9. Health care cost implications of sildenafil citrate. Miner M. J Sex Med; 2004 Sep 20; 1(2):141-9. PubMed ID: 16422968 [Abstract] [Full Text] [Related]
10. [Is it safe for cardiological patients to take sildenafil (viagra) to correct erectile dysfunction? (lectures)]. Metelitsa VI. Ter Arkh; 2000 Sep 20; 72(6):67-9. PubMed ID: 10900657 [No Abstract] [Full Text] [Related]
18. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D. Health Technol Assess; 2009 Oct 04; 13(49):1-320. PubMed ID: 19863849 [Abstract] [Full Text] [Related]